Vaccines - early clinical trials

G. Karakiulakis (Thessaloniki, Greece)

Source: Virtual Congress 2020 – Management prevention
Session: Management prevention
Session type: COVID-19
Number: 3620

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Karakiulakis (Thessaloniki, Greece). Vaccines - early clinical trials. Virtual Congress 2020 – Management prevention

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Current clinical trials
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017


Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021


The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013


Key role of patients in clinical trials
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013

Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


COVID-19: Vaccines – what are they and how do they work (current and trials)
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021



RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Late Breaking Abstract - Post-trial follow-up after a randomized clinical trial of COVID-19 convalescent plasma.
Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19
Year: 2021



Preschool asthma - have randomised controlled trials provided clarity on management?
Source: International Congress 2018 – Infectious agents and childhood asthma
Year: 2018


Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020